Table 2 Drugs used in treatment regimen (n = 49)
From: Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
Drug | Patients, n (%) |
|---|---|
Amikacin | 49 (100) |
Ethambutol | 29 (59.2) |
Pyrazinamide | 29 (59.2) |
Rifabutin | 3 (6.1) |
Levofloxacin | 7 (14.3) |
Moxifloxacin | 44 (89.8) |
Clofazimine | 44 (89.8) |
Linezolid | 26 (53.1) |
Ethionamide | 30 (61.2) |
Cycloserine | 30 (61.2) |
Para-aminosalicylic acid | 32 (65.3) |
Imipenem | 12 (24.5) |
Amoxicillin-clavulanate | 6 (12.2) |
Bedaquiline | 5 (10.2) |
Delamanid | 1 (2) |